About Institut Claudius Regaud; Departement Oncologie Medicale
Le campus de cancérologie de Toulouse, Oncopole, est un pôle de recherche sur le cancer à dimension européenne.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Institut Claudius Regaud; Departement Oncologie Medicale
During the past decade, Institut Claudius Regaud; Departement Oncologie Medicale conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 14 clinical trials were completed, i.e. on
average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Claudius Regaud; Departement Oncologie Medicale"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Institut Claudius Regaud; Departement Oncologie Medicale
According to Clinical.Site data, the most researched conditions in "Institut Claudius Regaud; Departement Oncologie Medicale" are
"Breast Cancer" (8 trials), "Ovarian Cancer" (4 trials), "Breast Neoplasms" (2 trials), "Colorectal Cancer" (2 trials) and "Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Institut Claudius Regaud; Departement Oncologie Medicale" in a lesser frequency.
Clinical Trials Intervention Types at Institut Claudius Regaud; Departement Oncologie Medicale
Most popular intervention types in "Institut Claudius Regaud; Departement Oncologie Medicale" are "Drug" (28 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (10 trials), "Paclitaxel" (10 trials), "Bevacizumab" (7 trials), "Trastuzumab" (6 trials) and "Docetaxel" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Institut Claudius Regaud; Departement Oncologie Medicale
The vast majority of trials in "Institut Claudius Regaud; Departement Oncologie Medicale" are
21 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Institut Claudius Regaud; Departement Oncologie Medicale
Currently, there are NaN active trials in "Institut Claudius Regaud; Departement Oncologie Medicale".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Institut Claudius Regaud; Departement Oncologie Medicale,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Institut Claudius Regaud; Departement Oncologie Medicale, 9 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".